Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The generalized repetitive fast discharge (GRFD) is an ictal pattern representing the EEG counterpart of tonic
seizures
occurring mainly in Lennox-Gastaut syndrome (LGS) during slow-wave sleep. The history of terminology, electromorphology, correlations with sleep, ictal clinical correlations and associations with different epileptic syndromes as well as the clinical significance of the pattern is described reviewing the pertinent literature and our own experiences. The physiopathogenesis from both the electrophysiological and pharmacological aspects is discussed in the framework of a concept according to which GRFD is considered as a malignant derivative of an existing slow spike-wave mechanism, due to the permanent or momentary breakdown of the GABA-ergic inhibitory process. In observations performed on some patients we found a paradoxical GRFD-eliciting effect of BDZ drugs and hexobarbiturate after chronic treatment with BDZ agents and/or barbiturate, and a GRFD-blocking effect of
Anexate
(Flumazenil), a BDZ antagonist on the pattern, appearing either spontaneously in slow-wave sleep or elicited by diazepam or barbiturate. Our findings support the assumption that BDZ (Barbiturate) GABA-Chloride Ionophore Complex plays an important role, both in the development of and possibly in the therapeutic approach to, the GRFD phenomena. Some hypotheses about the role played by the complex based on these observations are put forward.
...
PMID:Runs of rapid spikes in sleep: a characteristic EEG expression of generalized malignant epileptic encephalopathies. A conceptual review with new pharmacological data. 166 48
Flumazenil (
Lanexat
) is the first specific benzodiazepine-antagonist for clinical use. In several controlled investigations, a significant rapidly commencing antagonistic effect on the central effects of benzodiazepines has been demonstrated. Flumazenil possesses only slight side effects which may easily be treated. The immediate indications for employing flumazenil are reversal of the sedation caused by benzodiazepines in outpatients and treatment of cases of poisoning. In addition, flumazenil could be employed to reverse sedation produced by benzodiazepines during general anaesthesia and prolonged sedation in intensive care units. The following should be observed on employing flumazenil: 1. Flumazenil should be administered by slow meticulous titration. 2. The relatively short half-life of flumazenil provides the possibility for partial return of CNS depression. 3. In cases of mixed poisoning, flumazenil may unmask the effects of possible
seizure
-producing drugs. 4. Care should be employed in using flumazenil in chronic benzodiazepine abusers.
...
PMID:[Flumazenil. A specific benzodiazepine antagonist]. 250 84